US Stock MarketDetailed Quotes

VRDN Viridian Therapeutics

Watchlist

19.450
-0.380-1.92%

Close Dec 27 16:00 ET

19.450
0.0000.00%

Post 20:01 ET

1.54BMarket Cap-4.50P/E (TTM)

Viridian Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Viridian Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 7 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q1	-- / 42.860K	--
--	2024/Q4	-- / 48.770K	--
--	2024/Q3	86.000K / 49.580K	--
--	2024/Q2	72.000K / 91.690K	--
May 8, 2024	2024/Q1	72.000K / 79.830K	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q1-- / 42.860K--

--2024/Q4-- / 48.770K--

--2024/Q386.000K / 49.580K--

--2024/Q272.000K / 91.690K--

May 8, 20242024/Q172.000K / 79.830K--

Unlock Free Earnings Estimates

Open Account

Viridian Therapeutics Earnings Reports

Viridian Therapeutics | 8-K: Viridian Therapeutics Reports Third Quarter 2024 Financial Results and Recent Progress Including New FcRn Data

Nov 12 09:31 ET

Viridian Therapeutics | 10-Q: Q3 2024 Earnings Report

Nov 12 09:31 ET

Viridian Therapeutics | 8-K: Viridian Therapeutics Highlights Recent Progress and Reports Second Quarter 2024 Financial Results

Aug 8 08:29 ET

Viridian Therapeutics | 10-Q: Q2 2024 Earnings Report

Aug 8 08:04 ET

Analyst Rating

Updated: Dec 20, 2024

Strong Buy

Buy
92.86%
Hold
7.14%
Sell
0.00%

Price Target

No Data

Heat List

Overall